BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17.05.2002

Guidance for Industry on Special Protocol Assessment; Availability

The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Special Protocol Assessment." This guidance provides guidance for industry on procedures adopted by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) to evaluate issues related to the adequacy (e.g., design, conduct, analysis) of certain proposed studies.

Source: Federal Register — Food and Drug AdministrationOpen original release →